US20050261667A1 - Infusion device and method - Google Patents
Infusion device and method Download PDFInfo
- Publication number
- US20050261667A1 US20050261667A1 US11/191,053 US19105305A US2005261667A1 US 20050261667 A1 US20050261667 A1 US 20050261667A1 US 19105305 A US19105305 A US 19105305A US 2005261667 A1 US2005261667 A1 US 2005261667A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- shaft
- marker
- needle
- distal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0008—Catheters; Hollow probes having visible markings on its surface, i.e. visible to the naked eye, for any purpose, e.g. insertion depth markers, rotational markers or identification of type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/008—Strength or flexibility characteristics of the catheter tip
- A61M2025/0081—Soft tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0085—Multiple injection needles protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0085—Multiple injection needles protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
- A61M2025/0086—Multiple injection needles protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip the needles having bent tips, i.e. the needle distal tips are angled in relation to the longitudinal axis of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0089—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
- A61M2025/0091—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip the single injection needle being fixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/19—Constructional features of carpules, syringes or blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
Definitions
- PMR percutaneous myocardial revascularization
- the present invention includes improved devices and methods for performing PMR procedures.
- One device allows for improved preparation of PMR catheters used to inject a drug or therapeutic substance into the heart wall.
- One such device includes a PMR device distal region or hood disposed within the neck of a vial for receiving the drug.
- the vial can be used to receive the drug while the drug is being flushed through the PMR device and needle to prepare the PMR device for use.
- One vial has a neck and shoulder region for receiving and retaining the distal region of a PMR injection device.
- a no-leak gasket defines one wall of an inner cavity within one such vial.
- One set of devices provides improved needle attachment to drug delivery tubes.
- One improved drug delivery tube has an outer tube defining a lumen therein.
- a needle may be disposed within the distal end of the tube.
- the needle can have a distal, sharp tube region for insertion into the heart wall, as a well as a wider, more proximal region having outward protrusions for engaging or biting into the drug delivery tube inner wall.
- One device has a wide flange for abutting the drug delivery tube distal end, thereby limiting the proximal travel of the needle into the drug delivery tube lumen.
- One drug delivery tube also has a bonding hole which can be used to inject an adhesive to further secure the needle within the drug delivery tube distal region. The improved securing of the needle to the drug delivery tube can act to prevent the needle from being distally pulled from the tube.
- Another aspect of the invention provides improved visualization of the catheter shaft orientation under fluoroscopy.
- One embodiment utilizes asymmetrically disposed radiopaque markers on the shaft distal region to enable the treating physician to determine whether the catheter distal region is pointed at right angles to the treating physician or is pointed toward or away from the treating physician.
- One embodiment has the radiopaque marker being asymmetrically distributed with respect to a plane bisecting a longitudinal axis of the catheter tube distal region.
- Another embodiment further includes the radiopaque marker being asymmetrically distributed with respect to length over the catheter distal region.
- One marker includes an annular ring portion and a straight leg portion lying along the length of one side of the tube.
- radiopaque marker segments are asymmetrically distributed such that the rotation of the tube relative to the treating physician may be determined under fluoroscopy.
- One embodiment uses opposing annular shells on opposing sides of a tube where the annular shells are shifted longitudinally relative to each other. The asymmetrically disposed shells are thus asymmetric both with respect to a plane bisecting a longitudinal central access and with respect to a plane transversely bisecting a catheter shaft.
- marker bands are provided a distance apart which approximates the desired inter-treatment site spacing along the heart wall.
- a method can be performed using this aspect of the invention, whereby a therapeutic substance is delivered at treatment sites which are observed under fluoroscopy to be spaced apart approximately the distance between marker bands. Any distortion or magnification of the distances between marker bands will approximately be matched by distortions between treatment sites.
- the present invention also includes a PMR device for allowing precise, variable depth needle penetration of the heart wall.
- One device includes at least one inner stop affixed to a rotatable inner needle.
- the device also can have one or more stops disposed inwardly from an outer tube, the outer tube having the inner needle rotatably disposed within.
- the inner needle can be longitudinally advanced until the inner stop abuts an outer stop, thereby inhibiting further distal movement of the inner needle. If greater penetration is desired, the inner shaft can be rotated, thereby swinging the inner stop clear of the first encountered outer stop, allowing the inner stop to proceed further distally until a subsequent outer stop is encountered.
- This aspect of the invention allows a single device to be used, yet provides multiple, preset, precise penetration depths. This may be of particular use where the thickness of the heart wall varies over different regions of the heart chamber wall.
- FIGS. 6A-6C are perspective views of a catheter having an asymmetric radiopaque marker
- FIG. 10 is a fragmentary, longitudinal cross-sectional view of a PMR catheter having multiple stops for controlling needle penetration;
- drug delivery catheter preparing system 30 can be provided substantially as illustrated in FIG. 1 .
- Catheter 42 can be provided either separate from, or already engaged within, vial neck region 58 .
- catheter 42 distal portion 54 can be inserted into vial neck region 58 , if not already so disposed.
- Catheter 42 can be further advanced, forcing needle 50 through gasket 40 , and into cavity 34 .
- needle 50 inserted through gasket 40 the drug to be delivered can be flushed through needle 50 into cavity 34 , preferably mixing with a neutralizing agent. In this way, the drug to be delivered can be loaded into catheter 42 , preparing the catheter for use.
- the excess drug can be contained within cavity 34 , which may be desirable where the drug is potentially harmful or must be isolated for other reasons.
- Catheter 42 can be retracted from vial 32 when needed.
- Gasket 40 is preferably formed of a self-sealing material, such that a seal is re-formed after needle 50 is withdrawn.
- the contents of the vial will be harmless, even if the vial integrity is compromised.
- vial 32 can be disposed of in a proper manner.
- vial 32 containing either a harmless or a neutralized drug, may be disposed of in a wastebasket, with no special handling required.
- Needle threads 120 may be seen to engage or bite into tube wall 104 .
- threads 120 are disposed on the outside of needle 114 , and engage inner surface 108 of tube wall 104 .
- the proximal portion of the needle extends over tube 104 .
- threads are disposed inward within the needle lumen and engage tube outer surface 107 , rather than the inner surface.
- Needle 114 can be secured to tube 102 by advancing needle 114 into tube lumen 106 and rotating 114 , thereby screwing needle 114 into tube lumen 106 . Threads 120 thus secure needle 114 to tube 102 and resist the distally directed forces attempting to urge needle 114 out of tube 102 .
- FIG. 5B illustrates a view of catheter shaft 140 with shaft distal end 142 pointed more toward the viewer than away.
- FIG. 5C illustrates catheter shaft 140 having distal end 142 pointed more away from the viewer than toward the viewer.
- marker 144 appears differently when the catheter distal end is pointed away from the viewer compared to pointing toward the viewer.
- the asymmetric marker band 146 thus provides an indication under fluoroscopy of whether the catheter is pointed away from, or toward the viewer.
- FIG. 5D illustrates the asymmetric nature of radiopaque marker 144 .
- FIG. SD taken through annular ring portion 146 , shows a more proximal slice through catheter shaft 140 .
- FIG. 5E taken through a more distal portion of catheter 140 , illustrates marker 144 having straight leg portion 148 only on one side. It may be seen from FIGS. 5A through 5E that a plane bisecting the central longitudinal axis of catheter shaft 140 , will have differing, asymmetrical portions of radiopaque marker on either side of the bisecting plane. In particular, the markers on either side of the bisecting plane are not mirror images of each other.
Abstract
Devices and methods for performing improved percutaneous myocardial revascularization (PMR) procedures. One device includes a preassembled PMR drug delivery catheter and a drug neutralizing vial. The vial assembly allows prepping the PMR catheter by flushing drug through distal needle, and into a vial cavity where the drug is neutralized by a neutralizing agent. One set of devices includes needles having protrusions secured to the distal regions of drug delivery tubes. One needle has outward protruding barbs engaging the inner tube wall while another needle has outward threads which can screw into the tube inner wall. Radiopaque marker bands are also included in the present invention which are asymmetrically distributed on the catheter shaft, allowing a treating physician to determine under fluoroscopy whether the catheter distal region is pointed away or toward the treating physician, as well as determining whether the catheter distal region is rotated toward or away from the treating physician. PMR devices include catheters having dual injection needles, for both injecting a drug into the heart wall and a radiopaque contrast media to mark the already treated sites. One PMR injection device has multiple stops for allowing controlled, variable needle depth penetration with a single distal needle tip.
Description
- The present application is a continuation of U.S. application Ser. No. 10/621,378, which was filed on Jul. 18, 2003, was entitled Infusion Devices and Method and is now U.S. Pat. No. ______. The '378 application is itself a continuation of U.S. Pat. No. 6,616,626, which was filed on Dec. 21, 2000 and shares the same name.
- The present invention is related generally to medical devices. More specifically, the present invention is related to devices and methods associated with delivery of genes or therapeutic substances.
- A number of techniques are available for treating heart disease and diseases of other organs percutaneously. Examples of such techniques include delivery of genes and therapeutic substances, including the delivery of genes and therapeutic substances for percutaneous myocardial revascularization (PMR). This procedure is performed to increase blood perfusion through the myocardium of a patient. For example, in some patients, the number of lesions in coronary vessels is so great or the location so remote in the patient vasculature that restoring blood flow to the heart muscle is difficult. Percutaneous myocardial revascularization (PMR) has been developed as an alternative to techniques which are directed at bypassing or removing lesions. PMR is performed by boring holes directly into the myocardium of the heart. Positive results have been demonstrated in some human patients receiving PMR treatments. These results are believed to be caused in part by blood flowing from within a heart chamber through patent holes formed by PMR to the myocardial tissue. Suitable PMR holes have been proposed to be burned by laser, cut by mechanical means, and burned by radio frequency devices. Increased blood flow to the myocardium is also believed to be caused in part by the healing response to wound formation, specifically, the formation of new blood vessels in response to the newly created wound.
- Several aspects of PMR procedures could be improved upon. One area for improvement is in the preparation of PMR injection catheters for use by the treating physician. In particular, at present, the PMR device maybe flushed with a drug to prime the distal needle by flushing the drug through the needle and into a container. This preparation can be awkward and may leave a container of biologically active material which may require further processing. Another aspect which may be farther optimized lies in the attachment of the needle to the distal region of the PMR catheter tube. In particular, forces may act upon the needle during both the advancement and retraction of the needle within the heart wall, urging the needle undesirably both into and out of the tube. Improved methods of securing the needle to the tube would be desirable.
- During a PMR treatment, a physician may be attempting to treat a three-dimensional space using a catheter having a distal bend. In particular, the physician may be attempting to treat the heart chamber side, anterior, and posterior wall regions. This may presently be difficult to visualize under fluoroscopy as current marking systems for shafts may make interpretation of the catheter distal region orientation somewhat ambiguous. The heart chamber wall thickness can vary depending on the chamber and wall region being treated. In particular, the left ventricle wall is thinner in the posterior region relative to the anterior region. Improved devices for variable depth, yet controlled penetration of the heart walls, would be advantageous. As multiple sites of the heart chamber wall are penetrated, a system for tracking the treated versus untreated regions would also be desirable.
- The present invention includes improved devices and methods for performing PMR procedures. One device allows for improved preparation of PMR catheters used to inject a drug or therapeutic substance into the heart wall. One such device includes a PMR device distal region or hood disposed within the neck of a vial for receiving the drug. The vial can be used to receive the drug while the drug is being flushed through the PMR device and needle to prepare the PMR device for use. One vial has a neck and shoulder region for receiving and retaining the distal region of a PMR injection device. A no-leak gasket defines one wall of an inner cavity within one such vial.
- The vial is preferably formed of a transparent or translucent material for observing the injection of the drug into the vial. In one embodiment, the vial cavity includes a drug-neutralizing agent. The agent allows the drug to be neutralized after receiving the drug. A neutralizing agent can provide improved safety, should the integrity of the vial be breached. The drug-neutralizing vial allows a biologically active drug to be flushed through the catheter with the vial being disposed of in a normal waste stream such as a wastebasket, rather than requiring special handling.
- One set of devices provides improved needle attachment to drug delivery tubes. One improved drug delivery tube has an outer tube defining a lumen therein. A needle may be disposed within the distal end of the tube. The needle can have a distal, sharp tube region for insertion into the heart wall, as a well as a wider, more proximal region having outward protrusions for engaging or biting into the drug delivery tube inner wall. One device has a wide flange for abutting the drug delivery tube distal end, thereby limiting the proximal travel of the needle into the drug delivery tube lumen. One drug delivery tube also has a bonding hole which can be used to inject an adhesive to further secure the needle within the drug delivery tube distal region. The improved securing of the needle to the drug delivery tube can act to prevent the needle from being distally pulled from the tube.
- During insertion of the needle into the heart wall, forces can act to urge the needle into the tube. Upon retraction of the needle from the heart wall, forces may act to pull the needle distally from the tube. Both the outward protrusions, the flange, and the added adhesive can act to better secure the needle to the drug delivery tube. One embodiment includes outward barbs biting into the drug delivery tube, while another embodiment uses a series of helically disposed screw threads to engage the tube wall. A preferred embodiment uses outward protruding elements which engage the inner wall, while another embodiment uses inwardly protruding elements engaging the outer wall of the tube distal region.
- Another aspect of the invention provides improved visualization of the catheter shaft orientation under fluoroscopy. One embodiment utilizes asymmetrically disposed radiopaque markers on the shaft distal region to enable the treating physician to determine whether the catheter distal region is pointed at right angles to the treating physician or is pointed toward or away from the treating physician. One embodiment has the radiopaque marker being asymmetrically distributed with respect to a plane bisecting a longitudinal axis of the catheter tube distal region. Another embodiment further includes the radiopaque marker being asymmetrically distributed with respect to length over the catheter distal region. One marker includes an annular ring portion and a straight leg portion lying along the length of one side of the tube. Yet another embodiment includes an annular shell or ring portion and an annular arc leg portion extending along a length from the annular shell or ring portion. The radiopaque markers may be disposed on either the proximal or the distal side of any bend in the catheter shaft. A preferred use of the radiopaque marker band is on a guide catheter used to guide a PMR therapeutic tip to the heart wall.
- In yet another aspect of the invention, radiopaque marker segments are asymmetrically distributed such that the rotation of the tube relative to the treating physician may be determined under fluoroscopy. One embodiment uses opposing annular shells on opposing sides of a tube where the annular shells are shifted longitudinally relative to each other. The asymmetrically disposed shells are thus asymmetric both with respect to a plane bisecting a longitudinal central access and with respect to a plane transversely bisecting a catheter shaft.
- In still another aspect of the invention, marker bands are provided a distance apart which approximates the desired inter-treatment site spacing along the heart wall. A method can be performed using this aspect of the invention, whereby a therapeutic substance is delivered at treatment sites which are observed under fluoroscopy to be spaced apart approximately the distance between marker bands. Any distortion or magnification of the distances between marker bands will approximately be matched by distortions between treatment sites.
- The present invention also includes a PMR device for allowing precise, variable depth needle penetration of the heart wall. One device includes at least one inner stop affixed to a rotatable inner needle. The device also can have one or more stops disposed inwardly from an outer tube, the outer tube having the inner needle rotatably disposed within. The inner needle can be longitudinally advanced until the inner stop abuts an outer stop, thereby inhibiting further distal movement of the inner needle. If greater penetration is desired, the inner shaft can be rotated, thereby swinging the inner stop clear of the first encountered outer stop, allowing the inner stop to proceed further distally until a subsequent outer stop is encountered. This aspect of the invention allows a single device to be used, yet provides multiple, preset, precise penetration depths. This may be of particular use where the thickness of the heart wall varies over different regions of the heart chamber wall.
- Yet another aspect of the invention provides for injection of drug and contrast media into the heart wall. Injection of contrast media near the injection site of a drug allows the treating physician to visualize under fluoroscopy which areas of the heart wall have been treated and which have not yet been treated. One device provides a contrast media injection needle disposed side-by-side with a drug delivery needle. One embodiment allows the two side-by-side needles to be retracted and advanced together. The needles can be distally straight, arcuate, or one arcuate and one straight. Another embodiment provides a drug and contrast media injection device having a pair of needles, one being coaxially disposed within the other. The innermost needle can be used to inject drug deep into the heart tissue, while the more outer, coaxially disposed needle may be used to inject contrast media to the heart wall, thereby marking the site of treatment. One embodiment utilizes a sharp, cutting end to inject contrast media. Another embodiment uses a less sharp, less cutting end, for injecting a contrast media into the heart wall tissue using pressure, rather than cutting.
-
FIG. 1 is a fragmentary, side, cutaway view of a myocardial revascularization preparation system including a drug neutralizing vial and a myocardial revascularization drug delivery catheter in the process of being prepared for use by flushing a drug through the injection needle into the drug-neutralizing vial; -
FIG. 2 is a fragmentary, longitudinal, cross-sectional view of a drug delivery catheter distal portion having a needle disposed within a tube, the needle having barbs for engaging the tube inner wall to improve needle retention; -
FIG. 3 is a fragmentary, longitudinal, cross-sectional view of a drug delivery catheter distal portion having a needle disposed within a tube, the needle having threads for engaging the tube inner wall to improve needle retention; -
FIGS. 4A-4C are perspective views of a prior art catheter shaft having an annular radiopaque band; -
FIGS. 5A-5C are perspective views of a catheter shaft having an asymmetric radiopaque marker; -
FIGS. 5D-5E are transverse, cross-sectional views taken through the catheter ofFIGS. 5A-5C ; -
FIGS. 6A-6C are perspective views of a catheter having an asymmetric radiopaque marker; -
FIGS. 6D-6E are transverse, cross-sectional views taken through the catheter ofFIGS. 6A-6C ; -
FIG. 7 is a perspective view of a catheter shaft having an asymmetric, radiopaque marker disposed proximal of a bend; -
FIGS. 8A-8H are plan views of a catheter shaft having an asymmetric radiopaque marker in varying degrees of rotation; -
FIGS. 9A and 9B are perspective views of a guide catheter shaft including radiopaque marker bands having an inter-band distance corresponding to a desired myocardial revascularization treatment site spacing; -
FIG. 10 is a fragmentary, longitudinal cross-sectional view of a PMR catheter having multiple stops for controlling needle penetration; -
FIGS. 11A-11C are fragmentary, longitudinal cross-sectional views of a PMR catheter having side-by-side needles for injection of a drug and a radiopaque fluid; and -
FIGS. 12A-12B are fragmentary, longitudinal cross-sectional views of PMR devices having coaxially disposed drug and dye delivery lumens. -
FIG. 1 illustrates a myocardial revascularization drugdelivery preparation assembly 30 including adrug receiving vial 32 and adrug delivery catheter 42 inserted intovial 32.Drug delivery catheter 42 includes atube 44 having alumen 46 therethrough.Catheter 42 includes adistal portion 54 having an injection device orneedle 50 in fluid communication withlumen 46.Catheter 42 further includes adistal hood 48, illustrated in an expanded state.Drug injection needle 50 is illustrated penetrating through a self-sealing, no-leak gasket 40.Gasket 40 can be disposed withinvial 32 in anannular seat 52, as shown. -
Drug receiving vial 32 includes awall 38, which is preferably formed of a transparent or translucent material, allowing both an expelled drug and catheter needle to be viewed through the vial wall.Vial 32 includes acavity 34 having a drug-neutralizingagent 36 disposed withincavity 34.Vial 32 includes aneck region 58 for receiving catheterdistal portion 54. In one embodiment,vial 32 further includes a shoulder orcontour region 56 for engaging catheterdistal hood 48. In some embodiments,vial shoulder 56 andcatheter hood 48 are cooperatively sized such thatshoulder 56 engageshood 48 even whenhood 48 is in a non-expanded state.Hood 48 is preferably sufficiently compliant so as to allow retraction ofhood 48 throughvial neck region 58 after preparing the catheter.Vial shoulder 56 can also flex to containhood 48. - In use, drug delivery
catheter preparing system 30 can be provided substantially as illustrated inFIG. 1 .Catheter 42 can be provided either separate from, or already engaged within,vial neck region 58. Whencatheter 42 is to be prepared,catheter 42distal portion 54 can be inserted intovial neck region 58, if not already so disposed.Catheter 42 can be further advanced, forcingneedle 50 throughgasket 40, and intocavity 34. Withneedle 50 inserted throughgasket 40, the drug to be delivered can be flushed throughneedle 50 intocavity 34, preferably mixing with a neutralizing agent. In this way, the drug to be delivered can be loaded intocatheter 42, preparing the catheter for use. The excess drug can be contained withincavity 34, which may be desirable where the drug is potentially harmful or must be isolated for other reasons.Catheter 42 can be retracted fromvial 32 when needed.Gasket 40 is preferably formed of a self-sealing material, such that a seal is re-formed afterneedle 50 is withdrawn. In embodiments having a drug-neutralizing agent, the contents of the vial will be harmless, even if the vial integrity is compromised. After preparing,vial 32 can be disposed of in a proper manner. In some embodiments,vial 32, containing either a harmless or a neutralized drug, may be disposed of in a wastebasket, with no special handling required. -
Catheter 42 can be used to inject various drugs or other therapeutic substances into the myocardium. Examples of therapeutic substances include small molecular drugs, proteins, genes and cells which could promote angiogenesis, protect tissues (i.e., cardiac protection), or promote tissue regeneration. Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factors (FGFs) are believed suitable for use with the present invention. Carriers for the therapeutic agents of the present invention can include polymers, angiopoietins, biodegradable and biostable hydrogels, and dissoluble polymers. Adhesives suitable for binding the present invention include fibrin glues and cyanoacrylates which may also be included with the therapeutic substance to improve the desired response. Drug injection catheters referred to in the remainder of the present patent application, and drugs similarly referenced, may include the injection and use of the aforementioned therapeutic substances. -
Catheter 42, as well as subsequently referenced drug injection catheters or myocardial revascularization catheters, can include catheters such as those described in co-pending U.S. patent application Ser. No. 09/271,045, filed Mar. 17, 1999, entitled TRANSMYOCARDIAL REVASCULARIZATION CATHETER AND ASSEMBLY; and U.S. patent application Ser. No. 09/184,220, filed Nov. 2, 1998, entitled PERCUTANEOUS MYOCARDIAL REVASCULARIZATION GROWTH FACTOR MEDIUMS AND METHOD, herein incorporated by reference. In particular, guide catheters described according to the present invention may be used to guide these previously referenced devices, and others, to target sites in the myocardium. -
FIG. 2 illustrates the distal portion of adrug delivery catheter 60 which, in a preferred use, can be used for a procedure such as myocardial revascularization.Drug delivery catheter 60 includes a tube 62 having a wall 64 defining adrug delivery lumen 66 within.Catheter 60 has adistal region 68, terminating in adistal end 76. Disposed within catheter tube 62 is a drug delivery needle 78, including generally a wider, proximal portion 80, and a narrower,distal portion 82.Distal portion 82 includes anelongate tube 83 terminating in asharp end 84. Needle wide proximal portion 80, in the embodiment illustrated, includes a plurality ofwider protrusions 88 spaced apart from each other by a plurality of narrower regions 90.Protrusions 88, in a preferred embodiment, include sharp tips or barbs 86 for engaging and gripping tube wall 64. - As can be seen in
FIG. 2 , outward protrusions or barbs 86 may form a plurality ofdeformations 69 where the barbs dig into tube wall 64. In a preferred embodiment, barbs 86 have at least a slight inclination toward the distal direction, such that retraction of needle 78 from tube 62 is more difficult than insertion of needle 78 into tube 62. In a preferred embodiment,drug delivery catheter 60 includes adistal flange 72 which can serve to limit travel of needle 78 intodrug lumen 66. In the embodiment illustrated,flange 72 abuts tubedistal end 76 and has ahole 74 therethrough for receiving needledistal tube portion 83. In one embodiment, tube 62 includes abonding hole 70 through tube wall 64 for receiving adhesive. Adhesive can be injected throughhole 70 for improving the adherence of needle wide portion 80 to tubedistal region 68. - In one use,
drug delivery catheter 60 can be advanced through the vasculature and into a heart chamber wall. After injection of a drug throughdrug lumen 66,drug delivery catheter 60 can be retracted, thereby retracting needledistal end 84. In a situation where the heart wall grips needledistal tube portion 83, barbs or protrusions 86 can serve to resist the distally directed force attempting to retain needle 78. - Another
drug delivery catheter 100 is illustrated inFIG. 3 , having aneedle 114 disposed within atube 102.Tube 102 includes atube wall 104 having aninner surface 108 and anouter surface 107.Tube 102 includes adistal region 110, adistal end 112, and alumen 106 disposed therethrough.Needle 114 includes adistal tip region 116 ending distally in a sharpdistal end 118.Needle 114 also includes aproximal needle portion 118 including a plurality ofthreads 120 which are spaced apart and havenarrower regions 121 disposed betweenthreads 120.Needle 114 includes aneedle lumen 124 extending throughneedle 114 and having aproximal throat region 126.Throat 126 can improve the flow characteristics of fluid through the needle.Needle threads 120 may be seen to engage or bite intotube wall 104. In the embodiment illustrated,threads 120 are disposed on the outside ofneedle 114, and engageinner surface 108 oftube wall 104. In another embodiment, not requiring illustration, the proximal portion of the needle extends overtube 104. In this embodiment, threads are disposed inward within the needle lumen and engage tubeouter surface 107, rather than the inner surface.Needle 114 can be secured totube 102 by advancingneedle 114 intotube lumen 106 and rotating 114, thereby screwingneedle 114 intotube lumen 106.Threads 120 thussecure needle 114 totube 102 and resist the distally directed forces attempting to urgeneedle 114 out oftube 102. -
FIGS. 4A through 4C illustrate a priorart catheter shaft 130 having abend 134 and extending to adistal end 132.Catheter shaft 130 has anannular band 136 which includes a radiopaque material.FIG. 4A is a side view,viewing catheter shaft 130 from an angle of about ninety degrees (90.degree.) away from a straight-on end view looking directly along the central longitudinal axis.FIG. 4B illustratescatheter 130 viewed from an angle of less than ninety degrees (90.degree.) off the center longitudinal axis.FIG. 4B illustratescatheter shaft 130 wheredistal end 132 is pointed more toward the viewer than away.FIG. 4C illustratescatheter shaft 130 being pointed more away from than toward the viewer.FIGS. 4B and 4C illustrate that annularradiopaque band 136 looks somewhat elliptical, and looks about the same, whether viewed from the front or the back.Annular band 136 thus looks the same when catheter shaftdistal end 132 is pointed toward or away from the viewer. Annularradiopaque band 136 gives no indication under fluoroscopy of the direction the catheter shaft distal end is pointed. This is a less than optimal attribute of annularradiopaque band 136, when used in an application such as myocardial revascularization, where the catheter shaft may be rotated and translated in all directions. -
FIGS. 5A through 5E illustrate acatheter shaft 140 having an asymmetric radiopaque marker.Catheter shaft 140 includes abend 141 disposed proximal of a distal end 142.Catheter 140 includes an asymmetricradiopaque marker 144 including a first, annular orring portion 146 extending radially about the catheter and disposed transversely to the catheter longitudinal axis, and a second,straight portion 148, extending along one side ofshaft 140 toward distal end 142.FIG. 5A illustrates a side view ofcatheter shaft 140. The view ofFIG. 5A is taken from about ninety degrees (90.degree.) away from a straight-on end view, a view which would look directly along the central longitudinal axis.FIG. 5B illustrates a view ofcatheter shaft 140 with shaft distal end 142 pointed more toward the viewer than away.FIG. 5C illustratescatheter shaft 140 having distal end 142 pointed more away from the viewer than toward the viewer. As can be seen from inspection ofFIGS. 5B and 5C ,marker 144 appears differently when the catheter distal end is pointed away from the viewer compared to pointing toward the viewer. Theasymmetric marker band 146 thus provides an indication under fluoroscopy of whether the catheter is pointed away from, or toward the viewer. -
FIG. 5D illustrates the asymmetric nature ofradiopaque marker 144. FIG. SD, taken throughannular ring portion 146, shows a more proximal slice throughcatheter shaft 140.FIG. 5E , taken through a more distal portion ofcatheter 140, illustratesmarker 144 havingstraight leg portion 148 only on one side. It may be seen fromFIGS. 5A through 5E that a plane bisecting the central longitudinal axis ofcatheter shaft 140, will have differing, asymmetrical portions of radiopaque marker on either side of the bisecting plane. In particular, the markers on either side of the bisecting plane are not mirror images of each other. It may also be seen thatmarker 144, when compared proximal end to distal end, is asymmetric along its length. In particular,radiopaque marker 144 does not have a distal portion which is a mirror image of its more proximal portion. -
FIG. 6A illustrates acatheter 160 having aradiopaque marker 164 which is asymmetric and includes a first, annulararc shell portion 166, and a second,annular ring portion 168. InFIG. 6A , it may be seen that a plane bisecting the central longitudinal axis ofcatheter 160 would have an asymmetry with respect to the marker about the bisecting plane. In particular, the right and left halves ofcatheter 160 are not mirror images of each other. InFIG. 6A , catheterdistal end 160 is pointed directly at the viewer. InFIG. 6B ,catheter 160 is directed such that catheterdistal end 162 is pointed ninety degrees (90.degree.) away from the viewer, directly to the side. InFIG. 6C ,catheter 160 is pointed one hundred eighty degrees (180.degree.) away from the viewer, toward the back. Comparison ofFIGS. 6A through 6C illustrates thatmarker 164 appears differently depending whether catheterdistal end 162 is pointed toward the viewer, to the side of the viewer, or away from the viewer.FIG. 6D shows a transverse cross-section taken through radiopaqueannular shell 166.Annular arc shell 166 extends along the length of the catheter and substantially parallel to the central longitudinal axis, similar in some respects tostraight segment 140 ofFIGS. 5A through 5E , but wider.FIG. 6E shows a transverse cross-section taken throughmarker 164 throughannular ring 168. The asymmetry about the bisecting plane may be seen inFIGS. 6D and 6E , as well.Radiopaque marker 164 may also be seen to be asymmetric about a transverse bisecting plane. In particular, the top half ofmarker 164 inFIG. 6A is not the mirror image of a bottom half ofmarker 164 inFIG. 6A . - In comparing
FIGS. 5A through 5C and 6A through 6C, it may be seen that both embodiments, when viewed from an angle orthogonal to a plane containing the shaft on either side of the bend, have an asymmetric marker having two portions. The first portion lies substantially within a plane transverse to the center longitudinal axis. The second portion lies substantially within a plane that contains the center longitudinal axis. One embodiment has the marker disposed proximal of the bend, while the other embodiment has the marker disposed distal of the bend. One embodiment indicates shaft rotation proximal of the bend directly and infers the orientation of the segment distal of the bend. Another embodiment indicates shaft rotation distal of the bend directly and infers the orientation of the segment proximal of the bend. The other embodiment, not requiring illustration, has both the markers ofFIGS. 5A through 5C and 6A through 6C on the same shaft. -
FIG. 7 illustrates acatheter shaft 200 having a radiopaque marker 201 including afirst portion 206 and asecond portion 208.Catheter 200 has abend 202 and-adistal end 204. In the embodiment illustrated,catheter 200 has alumen 210 extending therethrough. As can be seen from inspection ofFIG. 7 , a plane bisecting the center longitudinal axis throughcatheter shaft 200 would bisect radiopaque marker 201 into twohalves first marker portion 206 andsecond marker portion 208 are not mirror images of each other with respect to a bisecting plane sending through the central axis. Radiopaque marker 201 is also not symmetrical with respect to a transverse bisecting plane. The asymmetry causes marker 201 to appear differently depending on the rotation of the tube with respect to a viewer. In particular, marker 201 will appear differently under fluoroscopy depending on the degree to which the catheter is rotated about its central, longitudinal axis proximal ofbend 202. -
FIG. 8A illustrates acatheter shaft 220 somewhat similar tocatheter shaft 200 ofFIG. 7 .Catheter shaft 220 has adistal end 224, a first or leftmarker portion 226, and a second orright marker portion 228. Together, first andsecond marker portions asymmetric marker 230 which is asymmetric about a bisecting plane extending through the center longitudinal axis ofcatheter shaft 220. InFIG. 8A ,catheter shaft 220 is rotated such that catheterdistal end 224 is disposed at an angle of zero degrees (0.degree.) relative to the viewer. Catheter shaftdistal end 224 is directed directly at the viewer.FIG. 8B illustratescatheter shaft 220 rotated at a forty-five degree (45.degree.) angle relative to the viewer, yet still remaining in a somewhat forward disposition. Similarly,FIG. 8C illustratescatheter 220 rotated at ninety degrees (90.degree.) relative to the viewer, andFIG. 8D has the catheter pointed at a one hundred thirty five degree (135.degree.) angle away from the viewer.FIG. 8E illustratescatheter shaft 220 being pointed directly away from the viewer, followed byFIG. 8F , which illustrates the same catheter pointing away from the viewer, but at an angle of two hundred twenty five degrees (225.degree.).FIG. 8G illustratescatheter shaft 220 being rotated sufficiently to point two hundred seventy degrees (270.degree.) relative to the line of view, toward the side. Finally,FIG. 8H illustratescatheter shaft 220 being pointed three hundred fifteen degrees (315.degree.) away from its initial location, pointing mainly toward the viewer, but at a slight angle to the left. - As can be seen from inspection of
FIGS. 8A through 8H ,catheter marker 230 appears differently under fluoroscopy depending on the rotation of the marker relative to the viewer. In particular, the marker is asymmetrically disposed on the catheter shaft such that rotation of the catheter about its longitudinal center axis appears different, relative to a fixed viewer orthogonal to the longitudinal axis of the catheter shaft. Marker 201 thus enables a viewer using fluoroscopy to determine the angle of rotation of the catheter shaft about its longitudinal axis. This can prove useful in a myocardial revascularization procedure, where turning the catheter in varying degrees can be important, as the degree of rotation may correspond to the location of holes formed in the heart chamber wall. -
FIG. 9A illustrates acatheter shaft 240 having abend 242 and adistal end 244.Catheter shaft 240 further has a firstradiopaque marker band 246 and a secondradiopaque marker band 248 disposed at a known distance “D1” apart. In a preferred embodiment,marker bands FIG. 9B illustratescatheter 240 being rotated toward and to the left of the viewer. Atreatment catheter 250 may be seen to extend from catheter shaftdistal end 244.Treatment catheter 250 may be seen to have atherapeutic tip 252. Afirst treatment site 254 is represented by an “X” inFIG. 9B . As illustrated inFIG. 9B ,therapeutic tip 252 has been moved to a distance of about “D2” fromfirst treatment site 254. In the embodiment illustrated,therapeutic tip 252 is about to treat asecond site 256, where the inter-site distance, D2, is substantially equal to the D1 distance. The marker bands may thus be used as a scale to accurately space the treatments sites in the heart chamber wall. The marker bands, being spaced apart about the same distance as the desired treatment spacing, will be subject to the same magnifications and/or distortions under fluoroscopy. This means that even if the distance between the markers appears distorted under fluoroscopy, the distance between target sites will likewise be distorted by about the same amount. -
FIG. 10 illustrates aPMR catheter 280 including aninner needle 282 rotatably disposed within anouter tube 284.Inner needle 282 includes ashaft 286, and can terminate distally in asharp needle tip 288.Outer tube 284 includes atube wall 290, and has a distal flange orhood 292. Ahole 293 is disposed withindistal flange 292 for receivingneedle tip 288. In the embodiment illustrated,inner needle 282 has aninner stop 294 secured toinner shaft 286.Inner stop 294 is secured toinner shaft 286 such that rotating the inner shaft rotates the inner stop. In this embodiment,outer tube 284 hasouter stops tube wall 290. As can be seen from inspection ofFIG. 10 ,inner stop 294, if advanced further distally, will encounterouter stop 295 which will limit the distal travel ofneedle tip 288. It may also be seen that rotatinginner shaft 286 by ninety degrees (90.degree.) will allowinner stop 294 to clearouter stop 294 and proceed distally further. In an embodiment whereinner stop 294 has a hemispherical configuration, rotatinginner shaft 286 by one hundred eighty degrees (180.degree.) would allowneedle tip 288 to travel distally, yet be stopped byouter stop 296, again requiring one hundred eighty degree (180.degree.) rotation to allow further distal travel of the needle tip. Thus, twisting the inner shaft can allow the depth of penetration to be controlled. In some embodiments, the inner and outer stops are formed of radiopaque material, allowing the degree of penetration to be observed under fluoroscopy. Having staggered stops, as illustrated inFIG. 10 , allows the penetration depths to be accurately controlled from the proximal end of the catheter. This may be of particular importance in PMR procedures due to the varying thickness of the heart wall. -
FIG. 11A illustrates aPMR device 400 extending from aproximal region 402 to adistal region 404 and having adistal flange 410.PMR device 400 includes anouter tube 408 defining anouter lumen 412 within and slidably containing aninner tube 414 having afirst lumen 416 and asecond lumen 418 disposed within. In one embodiment, the two lumens are formed within a multi-lumen extrusion ofinner tube 414. In another embodiment, the twolumens First lumen 416 may have a fluid injected through a firstmanifold port 420 disposed inproximal region 402 extending through afirst access tube 417 which can definefirst lumen 416 in the proximal region.First lumen 416 extends distally to afirst injection needle 426 which may be seen to have an arcuatedistal region 427. Similarly,second lumen 418 may be seen to extend from a secondmanifold port 422, through a secondproximal tube 419, extending distally to a second fluid injection needle 428. In the embodiment illustrated,first injection needle 426 is curved, while second injection needle 428 is substantially straight in the distal region. - In one embodiment,
first lumen 416 is used to inject radiopaque fluid, whilesecond lumen 418 is used to inject a drug as part of the PMR procedure. In another embodiment,first lumen 416 is used to inject a drug, whilesecond lumen 418 is used to inject a radiopaque material. In this latter embodiment, the straight needle 428 can be used to inject radiopaque material at the center of a circular pattern formed by the repeated injection of a drug throughfirst needle 426. Injection of the radiopaque fluid allows the treating physician to visualize under fluoroscopy which areas of the heart wall have already been treated with the drug. -
FIG. 11B illustrates a distalPMR device region 434, similar todistal region 404 ofFIG. 11A , and having similar proximal regions, but having a different configuration for the two distal needles. In the embodiment illustrated, the PMR device distal region includesouter tube 408,inner tube 414, and first andsecond lumens FIG. 11A .First needle 426 hasarcuate region 427. In this embodiment, asecond needle 430 is illustrated, also having arcuatedistal segment 432. In this embodiment, both first and second needles have arcuate distal regions.FIG. 11C illustratesdistal region 434 ofFIG. 1B , shown in a retracted configuration.First needle 426 andsecond needle 430 may be seen to be retracted withinouter tube 408. -
FIGS. 12A and 12B illustrate other embodiments of PMR device distal regions, with the proximal regions not requiring illustration and having somewhat similar designs to those ofFIG. 11A .FIG. 12A illustrates aPMR device 440 including adistal region 444 and having a distalatraumatic flange 446.PMR device 440 includes anouter tube 448 defining anouter lumen 450 within.Outer lumen 450 includes within an intermediate orfirst tube 452 defining an intermediate orfirst lumen 454 within.Intermediate lumen 454 includes within an inner orsecond tube 456 defining an inner orsecond lumen 458 within.Intermediate lumen tube 452 extends distally and terminates in adistal injection tip 462. Second orinner tube 456 extends distally, terminating in adistal injection tip 463. - In one embodiment,
first lumen 454 is used to inject a drug throughneedle 462. In this embodiment, second orintermediate lumen 458 is used to inject a radiopaque dye through second orintermediate needle 463. In the embodiment illustrated inFIG. 12A ,intermediate tube 452 can be slidably disposed within theouter tube 444, and can haveinner tube 456 slidably disposed within. In another embodiment, the functions of the first and second lumens are reversed relative to the aforementioned embodiment. In this embodiment,inner needle 463 is used to inject dye, whileintermediate needle 462 is used to inject a drug. Injecting a radiopaque dye or contrast media allows the treating physician to observe which areas of the heart wall have been treated and which have not been treated, under fluoroscopy. -
FIG. 12B illustrates aPMR device 480 including adistal region 484 and having a distalatraumatic flange 486. A first material may be injected through a proximal manifold port, through afirst lumen 492 defined within a first orintermediate tube 490. The first material or fluid may be injected throughintermediate tube 490, being injected into tissue through a firstdistal tip 494. A second material or fluid may be injected through a second or inner manifold port, flowing through aninner lumen 500 defined within aninner tube 498. The second media may be injected distally into tissue through a innerdistal tip 502. - In the illustrated embodiment,
tube 490 is fixed relative toouter tube 484, whileinner tube 498 can be slidably disposed with respect totube 490. In this embodiment, radiopaque contrast media may be injected at approximately the same site as a drug delivered in a PMR procedure. In one embodiment, a drug is injected throughinner tip 502, while a contrast media is injected throughtip 494. In another embodiment, contrast media is injected throughtip 502, while a drug or other therapeutic substance is delivered through the outerdistal tip 494. In the embodiment illustrated inFIG. 12B , outerdistal tip 494 is relatively rounded at the end, with pressure being used to force material into the heart wall, rather than relying primarily on needle penetration.PMR device 480 also allows injection of contrast media near the site of drug injection. This allows the treating physician to observe the location of sites treated by PMR under fluoroscopy, distinguishing the treated sites from the untreated areas. - Numerous advantages of the invention covered by this document have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Claims (12)
1. A catheter comprising:
an elongate shaft having a central longitudinal axis, a radial dimension extending outward from said central axis, and a distal region, wherein a plane bisecting said shaft through said longitudinal axis defines a shaft first portion and a shaft second portion opposite said shaft first portion; and
a radiopaque marker disposed in said shaft distal region, wherein said radiopaque marker is asymmetric about said bisecting plane, such that said catheter distal portion appears differently under fluoroscopy when viewed from an angle less than ninety degrees (90°) to said plane than when viewed from an angle greater than ninety degrees (90°) to said plane.
2. A catheter as in claim 1 , wherein said marker is asymmetric with respect to a transverse bisecting plane through said shaft and marker.
3. A catheter as in claim 1 , wherein said marker includes more than one region, and said regions are contiguous with each other.
4. A catheter as in claim 1 , wherein said marker includes a first portion transverse to said central longitudinal axis and a second portion parallel to said longitudinal axis.
5. A catheter as in claim 1 , wherein said marker includes more than one region, and said regions are not all contiguous with each other.
6. A catheter as in claim 1 , wherein said radiopaque marker includes a first arcuate portion disposed about said shaft and a second linear portion disposed along said shaft and substantially parallel to said shaft longitudinal axis.
7. A catheter as in claim 6 , wherein said first arcuate portion includes an annular portion about said shaft and contiguous with said second marker portion.
8. A catheter as in claim 1 , wherein said marker includes a first portion extending along said shaft length parallel to said central longitudinal axis and a second portion extending transversely to said shaft central axis.
9. A catheter as in claim 8 , wherein said shaft has a length and a circumference, wherein said marker first portion includes an arcuate shell extending along said shaft length in an annular fashion around less than all of said shaft length in an annular fashion around less than all of said shaft circumference, wherein said second marker portion is an annular band extending transversely to said central axis.
10. A catheter as in claim 1 , wherein said first marker portion includes a first arcuate shell on one side of said bisection plane, wherein said second marker portion includes a second arcuate shell disposed on the other side of said bisection plane relative to said first arcuate shell, wherein said first and second arcuate shells are disposed over different lengths on said shaft.
11. A catheter as in claim 10 , wherein said catheter shaft has a bend, and said marker is disposed proximal of said bend.
12. A catheter as in claim 10 , wherein said arcuate shells are substantially annular.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/191,053 US20050261667A1 (en) | 2000-12-21 | 2005-07-28 | Infusion device and method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/747,157 US6616626B2 (en) | 2000-12-21 | 2000-12-21 | Infusion devices and method |
US10/621,378 US6939322B2 (en) | 2000-12-21 | 2003-07-18 | Infusion devices and method |
US11/191,053 US20050261667A1 (en) | 2000-12-21 | 2005-07-28 | Infusion device and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/621,378 Continuation US6939322B2 (en) | 2000-12-21 | 2003-07-18 | Infusion devices and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050261667A1 true US20050261667A1 (en) | 2005-11-24 |
Family
ID=25003883
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/747,157 Expired - Fee Related US6616626B2 (en) | 2000-12-21 | 2000-12-21 | Infusion devices and method |
US10/621,378 Expired - Lifetime US6939322B2 (en) | 2000-12-21 | 2003-07-18 | Infusion devices and method |
US11/191,053 Abandoned US20050261667A1 (en) | 2000-12-21 | 2005-07-28 | Infusion device and method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/747,157 Expired - Fee Related US6616626B2 (en) | 2000-12-21 | 2000-12-21 | Infusion devices and method |
US10/621,378 Expired - Lifetime US6939322B2 (en) | 2000-12-21 | 2003-07-18 | Infusion devices and method |
Country Status (6)
Country | Link |
---|---|
US (3) | US6616626B2 (en) |
EP (1) | EP1351646B1 (en) |
AU (2) | AU2002227414A8 (en) |
CA (1) | CA2431421C (en) |
DE (1) | DE60139573D1 (en) |
WO (1) | WO2002049695A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7156872B2 (en) * | 2000-10-26 | 2007-01-02 | Ernst Peter Strecker | Implantable valve system |
US20090143748A1 (en) * | 2007-08-09 | 2009-06-04 | Boston Scientific Scimed, Inc | Catheter Devices for Myocardial Injections or Other Uses |
US20090209943A1 (en) * | 2006-07-26 | 2009-08-20 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8298187B2 (en) | 2009-07-07 | 2012-10-30 | Cook Medical Technologies Llc | Fluid injection device |
US8353881B2 (en) * | 2005-12-28 | 2013-01-15 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
US8512244B2 (en) | 2006-06-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8641618B2 (en) | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US9616204B2 (en) | 2012-03-02 | 2017-04-11 | Cook Medical Technologies LLC. | Dilation cap for endoluminal device |
EP4061460A4 (en) * | 2019-11-20 | 2023-08-23 | Clph, Llc | Isolation and attachment catheters and methods for using them |
US11967408B2 (en) | 2019-02-12 | 2024-04-23 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6854467B2 (en) * | 2000-05-04 | 2005-02-15 | Percardia, Inc. | Methods and devices for delivering a ventricular stent |
SE516673C2 (en) * | 2000-07-27 | 2002-02-12 | Q Med Ab | Arrangement and method of cooperation with an internal body organ |
US20020032478A1 (en) * | 2000-08-07 | 2002-03-14 | Percardia, Inc. | Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel |
US6616626B2 (en) * | 2000-12-21 | 2003-09-09 | Scimed Life Systems, Inc. | Infusion devices and method |
US7357794B2 (en) * | 2002-01-17 | 2008-04-15 | Medtronic Vascular, Inc. | Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
US6785571B2 (en) * | 2001-03-30 | 2004-08-31 | Neil David Glossop | Device and method for registering a position sensor in an anatomical body |
US7169127B2 (en) * | 2002-02-21 | 2007-01-30 | Boston Scientific Scimed, Inc. | Pressure apron direct injection catheter |
US7108685B2 (en) * | 2002-04-15 | 2006-09-19 | Boston Scientific Scimed, Inc. | Patch stabilization of rods for treatment of cardiac muscle |
DE50201006D1 (en) * | 2002-04-16 | 2004-10-21 | Brainlab Ag | Marker for an instrument and method for locating a marker |
DE60325791D1 (en) | 2002-08-01 | 2009-02-26 | Abbott Lab Vascular Entpr Ltd | Injection device for sealing puncture wounds |
US7678122B2 (en) * | 2002-09-20 | 2010-03-16 | Id, Llc | Method of performing a treatment for gastroesophagheal reflux disease (GERD) |
US8454628B2 (en) | 2002-09-20 | 2013-06-04 | Syntheon, Llc | Surgical fastener aligning instrument particularly for transoral treatment of gastroesophageal reflux disease |
EP1578484A4 (en) * | 2002-12-16 | 2007-05-30 | Meagan Medical Inc | Controlling the depth of percutaneous applications |
AU2003245593B2 (en) | 2003-06-20 | 2010-06-03 | Apollo Endosurgery, Inc. | Two-way slit valve |
US7879024B2 (en) * | 2003-06-26 | 2011-02-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Splittable cannula having radiopaque marker |
US20080264102A1 (en) | 2004-02-23 | 2008-10-30 | Bolton Medical, Inc. | Sheath Capture Device for Stent Graft Delivery System and Method for Operating Same |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US9198786B2 (en) | 2003-09-03 | 2015-12-01 | Bolton Medical, Inc. | Lumen repair device with capture structure |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US20070198078A1 (en) | 2003-09-03 | 2007-08-23 | Bolton Medical, Inc. | Delivery system and method for self-centering a Proximal end of a stent graft |
US7396351B2 (en) | 2003-11-05 | 2008-07-08 | Boston Scientific Scimed, Inc. | Device and method for the delivery of viscous fluids in the body |
US7678077B2 (en) * | 2004-02-20 | 2010-03-16 | Boston Scientific Scimed, Inc. | Variable depth injection device and method |
DE102004020855B4 (en) * | 2004-04-28 | 2009-06-10 | Erbe Elektromedizin Gmbh | Applicator for waterjet surgery |
US7758541B2 (en) * | 2004-08-17 | 2010-07-20 | Boston Scientific Scimed, Inc. | Targeted drug delivery device and method |
WO2006031596A2 (en) * | 2004-09-09 | 2006-03-23 | Onset Medical Corporation | Expandable gastrointestinal sheath |
US8252016B2 (en) | 2005-01-13 | 2012-08-28 | Azam Anwar | System and method for providing embolic protection |
US20060200168A1 (en) * | 2005-03-03 | 2006-09-07 | Azam Anwar | System and method for providing access in divergent directions in a vascular environment |
US8092464B2 (en) * | 2005-04-30 | 2012-01-10 | Warsaw Orthopedic, Inc. | Syringe devices and methods useful for delivering osteogenic material |
US20070060929A1 (en) * | 2005-09-13 | 2007-03-15 | Norio Onishi | Treating implement cartridge of living body tissue |
US7713232B2 (en) * | 2005-11-04 | 2010-05-11 | Medrad, Inc. | System for washing and processing of cells for delivery thereof to tissue |
US8182444B2 (en) * | 2005-11-04 | 2012-05-22 | Medrad, Inc. | Delivery of agents such as cells to tissue |
US20070142849A1 (en) * | 2005-12-16 | 2007-06-21 | Usgi Medical, Inc. | Helical tissue manipulation instruments and methods of use |
ITNA20060112A1 (en) * | 2006-09-08 | 2008-03-09 | Ciro Indolfi | CABLE CATHETER WITH MORE THAN TWO RADIO-OPAQUE MARKERS FOR THE MEASUREMENT OF ARTERIAL SEGMENTS IN ASSOCIATION WITH THE USE OF X-RAYS. |
US20080065049A1 (en) * | 2006-09-12 | 2008-03-13 | Boston Scientific Scimed, Inc. | Variable stiffness direct injection system |
US20080086111A1 (en) * | 2006-10-09 | 2008-04-10 | Medrad, Inc. | Fluid delivery systems and volume metering in cell delivery |
CN103083794B (en) | 2007-08-14 | 2016-03-02 | 弗雷德哈钦森癌症研究中心 | For needle array assembly and the method for delivering therapeutic agents |
US8636670B2 (en) | 2008-05-13 | 2014-01-28 | The Invention Science Fund I, Llc | Circulatory monitoring systems and methods |
US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
WO2010005524A2 (en) | 2008-06-30 | 2010-01-14 | Bolton Medical, Inc. | Abdominal aortic aneurysms: systems and methods of use |
WO2010011930A2 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Scimed, Inc. | Various catheter devices for myocardial injections or other uses |
US7798995B2 (en) * | 2008-10-10 | 2010-09-21 | Laborie Medical Technologies, Inc. | Adjustable tip needle apparatus |
AU2009322968B2 (en) * | 2008-12-05 | 2015-09-10 | Ams Research Corporation | Devices, systems and methods for delivering fluid to tissue |
US8366657B2 (en) * | 2008-12-05 | 2013-02-05 | Ams Research Corporation | Needleless injection device components, systems, and methods |
AU2015268621B2 (en) * | 2008-12-05 | 2017-06-22 | Ams Research Corporation | Devices, systems and methods for delivering fluid to tissue |
EP3284447B1 (en) | 2009-03-13 | 2020-05-20 | Bolton Medical Inc. | System for deploying an endoluminal prosthesis at a surgical site |
CN102648016A (en) * | 2009-07-23 | 2012-08-22 | 适宜卫生科技项目公司 | Intradermal injection adapter |
US8731642B2 (en) * | 2009-11-08 | 2014-05-20 | Paieon Inc. | Apparatus and method for locating a device tip within a volume |
WO2011112916A1 (en) * | 2010-03-12 | 2011-09-15 | Sid Technologies, Llc | Assembly for use with a syringe |
US9955940B1 (en) * | 2010-04-23 | 2018-05-01 | Avent, Inc. | Echogenic nerve block catheter and echogenic catheter tip |
US9962500B2 (en) * | 2011-04-28 | 2018-05-08 | Sanofi-Aventis Deutschland Gmbh | Connection for medical device |
WO2012147408A1 (en) * | 2011-04-28 | 2012-11-01 | テルモ株式会社 | Hypodermic needle assembly and drug injection device |
EP2771043A4 (en) | 2011-10-28 | 2015-04-29 | Presage Biosciences Inc | Methods for drug delivery |
CN104363862B (en) | 2012-04-12 | 2016-10-05 | 波顿医疗公司 | Blood vessel prosthesis conveyer device and using method |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US9474865B2 (en) | 2013-04-25 | 2016-10-25 | West Pharmaceutical Services, Inc. | Needle shield for disposable syringe with annular ring |
WO2016031071A1 (en) * | 2014-08-29 | 2016-03-03 | Usciジャパン株式会社 | Medical catheter |
US10357636B2 (en) | 2015-10-28 | 2019-07-23 | Becton, Dickinson And Company | IV access device having an angled paddle grip |
US10639455B2 (en) | 2015-10-28 | 2020-05-05 | Becton, Dickinson And Company | Closed IV access device with paddle grip needle hub and flash chamber |
US10744305B2 (en) | 2015-10-28 | 2020-08-18 | Becton, Dickinson And Company | Ergonomic IV systems and methods |
US10814106B2 (en) | 2015-10-28 | 2020-10-27 | Becton, Dickinson And Company | Soft push tabs for catheter adapter |
US10525237B2 (en) | 2015-10-28 | 2020-01-07 | Becton, Dickinson And Company | Ergonomic IV systems and methods |
US10549072B2 (en) | 2015-10-28 | 2020-02-04 | Becton, Dickinson And Company | Integrated catheter with independent fluid paths |
US10245416B2 (en) | 2015-10-28 | 2019-04-02 | Becton, Dickinson And Company | Intravenous catheter device with integrated extension tube |
USD835262S1 (en) | 2016-10-05 | 2018-12-04 | Becton, Dickinson And Company | Intravenous catheter assembly |
USD819802S1 (en) | 2016-10-05 | 2018-06-05 | Becton, Dickinson And Company | Catheter adapter |
US10238852B2 (en) * | 2016-10-05 | 2019-03-26 | Becton, Dickinson And Company | Septum housing |
USD837368S1 (en) | 2016-10-05 | 2019-01-01 | Becton, Dickinson And Company | Catheter adapter grip |
US11400270B2 (en) * | 2017-02-06 | 2022-08-02 | Microvention, Inc. | Delivery adapter |
EP3799575A1 (en) * | 2018-06-04 | 2021-04-07 | Upstream Peripheral Technologies Ltd. | Axial sharp needle reentry device |
EP4011431A4 (en) * | 2019-08-13 | 2022-10-19 | TERUMO Kabushiki Kaisha | Catheter and diagnostic method |
US10653911B1 (en) * | 2019-08-14 | 2020-05-19 | Phong Duy Bui | System for liquid narcotic medication validation and deactivation |
Citations (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4279252A (en) * | 1979-08-24 | 1981-07-21 | Martin Michael T | X-ray scaling catheter |
US4434822A (en) * | 1979-11-05 | 1984-03-06 | Baxter Travenol Laboratories, Inc. | System for the sterile mixing of materials |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
US4790311A (en) * | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
US4896671A (en) * | 1988-08-01 | 1990-01-30 | C. R. Bard, Inc. | Catheter with contoured ablation electrode |
US5047026A (en) * | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
US5093877A (en) * | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5203777A (en) * | 1992-03-19 | 1993-04-20 | Lee Peter Y | Radiopaque marker system for a tubular device |
US5261889A (en) * | 1992-11-24 | 1993-11-16 | Boston Scientific Corporation | Injection therapy catheter |
US5287861A (en) * | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5358485A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5364393A (en) * | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5380316A (en) * | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5403311A (en) * | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5429256A (en) * | 1994-01-24 | 1995-07-04 | Kestenbaum; Alan D. | Drug withdrawal system for container |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5522815A (en) * | 1993-03-29 | 1996-06-04 | Durgin, Jr.; Russell F. | Integrated catheter for diverse in situ tissue therapy |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
US5569462A (en) * | 1993-09-24 | 1996-10-29 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
US5591159A (en) * | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5607405A (en) * | 1992-05-19 | 1997-03-04 | Decker; Rand A. | Surgical insertion device and method |
US5620414A (en) * | 1992-06-30 | 1997-04-15 | Campbell, Jr.; Robert M. | Apparatus and method for effecting surgical incision through use of a fluid jet |
US5672174A (en) * | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5697882A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5700259A (en) * | 1990-09-24 | 1997-12-23 | Plc Medical Systems, Inc. | Thoracoscopic transmyocardial revascularization handpiece assembly |
US5713894A (en) * | 1996-02-27 | 1998-02-03 | Murphy-Chutorian; Douglas | Combined mechanical/optical system for transmyocardial revascularization |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5810836A (en) * | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5905594A (en) * | 1995-01-06 | 1999-05-18 | W. L. Gore & Associates, Inc. | Light reflectant surface in a recessed cavity substantially surrounding a compact fluorescent lamp |
US6036682A (en) * | 1997-12-02 | 2000-03-14 | Scimed Life Systems, Inc. | Catheter having a plurality of integral radiopaque bands |
US6042581A (en) * | 1996-11-08 | 2000-03-28 | Thomas J. Fogarty | Transvascular TMR device and method |
US6045565A (en) * | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6053924A (en) * | 1996-11-07 | 2000-04-25 | Hussein; Hany | Device and method for trans myocardial revascularization |
US6056742A (en) * | 1997-02-03 | 2000-05-02 | Eclipse Surgical Technologies, Inc. | Revascularization with laser outputs |
US6056743A (en) * | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US6217554B1 (en) * | 1999-02-12 | 2001-04-17 | Pharmaspec Corporation | Methods and apparatus for delivering substances into extravascular tissue |
US6285903B1 (en) * | 1998-06-30 | 2001-09-04 | Eclipse Surgical Technologies, Inc. | Intracorporeal device with radiopaque marker |
US6464693B1 (en) * | 2000-03-06 | 2002-10-15 | Plc Medical Systems, Inc. | Myocardial revascularization |
US6544231B1 (en) * | 2000-05-22 | 2003-04-08 | Medcanica, Inc. | Catch, stop and marker assembly for a medical instrument and medical instrument incorporating the same |
US6613017B1 (en) * | 2000-08-08 | 2003-09-02 | Scimed Life Systems, Inc. | Controlled depth injection device and method |
US6616626B2 (en) * | 2000-12-21 | 2003-09-09 | Scimed Life Systems, Inc. | Infusion devices and method |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5651785A (en) | 1993-09-20 | 1997-07-29 | Abela Laser Systems, Inc. | Optical fiber catheter and method |
CA2220689A1 (en) | 1995-05-10 | 1996-11-14 | Cardiogenesis Corporation | System for treating or diagnosing heart tissue |
DE19537084A1 (en) | 1995-10-05 | 1997-04-10 | Sievers Hans Hinrich Prof Dr M | Catheter for transmyocardial revasculation with guidable multi=ID main catheter |
US5769843A (en) | 1996-02-20 | 1998-06-23 | Cormedica | Percutaneous endomyocardial revascularization |
IL118352A0 (en) | 1996-05-21 | 1996-09-12 | Sudai Amnon | Apparatus and methods for revascularization |
DE29609350U1 (en) | 1996-05-24 | 1996-08-29 | P Osypka Mbh Ges Fuer Medizint | Device for perforating the heart wall |
EP0949910A4 (en) | 1996-08-08 | 2001-01-17 | Localmed Inc | Transmural drug delivery method and apparatus |
JP2002500523A (en) | 1996-10-17 | 2002-01-08 | エチコン・エンド―サージエリー・インコーポレーテツド | Method and apparatus for improving blood flow to a patient's heart |
US6030377A (en) | 1996-10-21 | 2000-02-29 | Plc Medical Systems, Inc. | Percutaneous transmyocardial revascularization marking system |
US5906594A (en) * | 1997-01-08 | 1999-05-25 | Symbiosis Corporation | Endoscopic infusion needle having dual distal stops |
WO2000015146A1 (en) | 1998-09-10 | 2000-03-23 | Percardia, Inc. | Transmyocardial shunt for left ventricular revascularization |
US6312402B1 (en) | 1998-09-24 | 2001-11-06 | Ekos Corporation | Ultrasound catheter for improving blood flow to the heart |
-
2000
- 2000-12-21 US US09/747,157 patent/US6616626B2/en not_active Expired - Fee Related
-
2001
- 2001-12-20 WO PCT/US2001/048839 patent/WO2002049695A2/en not_active Application Discontinuation
- 2001-12-20 AU AU2002227414A patent/AU2002227414A8/en not_active Abandoned
- 2001-12-20 EP EP01996266A patent/EP1351646B1/en not_active Expired - Lifetime
- 2001-12-20 DE DE60139573T patent/DE60139573D1/en not_active Expired - Lifetime
- 2001-12-20 CA CA002431421A patent/CA2431421C/en not_active Expired - Fee Related
- 2001-12-20 AU AU2002227414A patent/AU2002227414A1/en not_active Abandoned
-
2003
- 2003-07-18 US US10/621,378 patent/US6939322B2/en not_active Expired - Lifetime
-
2005
- 2005-07-28 US US11/191,053 patent/US20050261667A1/en not_active Abandoned
Patent Citations (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4279252A (en) * | 1979-08-24 | 1981-07-21 | Martin Michael T | X-ray scaling catheter |
US4434822A (en) * | 1979-11-05 | 1984-03-06 | Baxter Travenol Laboratories, Inc. | System for the sterile mixing of materials |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
US4790311A (en) * | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
US4896671A (en) * | 1988-08-01 | 1990-01-30 | C. R. Bard, Inc. | Catheter with contoured ablation electrode |
US5047026A (en) * | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
US5364393A (en) * | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
US5700259A (en) * | 1990-09-24 | 1997-12-23 | Plc Medical Systems, Inc. | Thoracoscopic transmyocardial revascularization handpiece assembly |
US5093877A (en) * | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
US5380316A (en) * | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5697882A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5358485A (en) * | 1992-01-13 | 1994-10-25 | Schneider (Usa) Inc. | Cutter for atherectomy catheter |
US5203777A (en) * | 1992-03-19 | 1993-04-20 | Lee Peter Y | Radiopaque marker system for a tubular device |
US5607405A (en) * | 1992-05-19 | 1997-03-04 | Decker; Rand A. | Surgical insertion device and method |
US5620414A (en) * | 1992-06-30 | 1997-04-15 | Campbell, Jr.; Robert M. | Apparatus and method for effecting surgical incision through use of a fluid jet |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5287861A (en) * | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5261889A (en) * | 1992-11-24 | 1993-11-16 | Boston Scientific Corporation | Injection therapy catheter |
US5403311A (en) * | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5522815A (en) * | 1993-03-29 | 1996-06-04 | Durgin, Jr.; Russell F. | Integrated catheter for diverse in situ tissue therapy |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5569462A (en) * | 1993-09-24 | 1996-10-29 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
US5429256A (en) * | 1994-01-24 | 1995-07-04 | Kestenbaum; Alan D. | Drug withdrawal system for container |
US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5591159A (en) * | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
US5905594A (en) * | 1995-01-06 | 1999-05-18 | W. L. Gore & Associates, Inc. | Light reflectant surface in a recessed cavity substantially surrounding a compact fluorescent lamp |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
US5672174A (en) * | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5713894A (en) * | 1996-02-27 | 1998-02-03 | Murphy-Chutorian; Douglas | Combined mechanical/optical system for transmyocardial revascularization |
US5810836A (en) * | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US6053924A (en) * | 1996-11-07 | 2000-04-25 | Hussein; Hany | Device and method for trans myocardial revascularization |
US6053911A (en) * | 1996-11-08 | 2000-04-25 | Thomas J. Fogarty | Transvascular TMR device and method |
US6042581A (en) * | 1996-11-08 | 2000-03-28 | Thomas J. Fogarty | Transvascular TMR device and method |
US6056742A (en) * | 1997-02-03 | 2000-05-02 | Eclipse Surgical Technologies, Inc. | Revascularization with laser outputs |
US6045565A (en) * | 1997-11-04 | 2000-04-04 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization growth factor mediums and method |
US6056743A (en) * | 1997-11-04 | 2000-05-02 | Scimed Life Systems, Inc. | Percutaneous myocardial revascularization device and method |
US6036682A (en) * | 1997-12-02 | 2000-03-14 | Scimed Life Systems, Inc. | Catheter having a plurality of integral radiopaque bands |
US6285903B1 (en) * | 1998-06-30 | 2001-09-04 | Eclipse Surgical Technologies, Inc. | Intracorporeal device with radiopaque marker |
US6217554B1 (en) * | 1999-02-12 | 2001-04-17 | Pharmaspec Corporation | Methods and apparatus for delivering substances into extravascular tissue |
US6464693B1 (en) * | 2000-03-06 | 2002-10-15 | Plc Medical Systems, Inc. | Myocardial revascularization |
US6544231B1 (en) * | 2000-05-22 | 2003-04-08 | Medcanica, Inc. | Catch, stop and marker assembly for a medical instrument and medical instrument incorporating the same |
US6613017B1 (en) * | 2000-08-08 | 2003-09-02 | Scimed Life Systems, Inc. | Controlled depth injection device and method |
US6616626B2 (en) * | 2000-12-21 | 2003-09-09 | Scimed Life Systems, Inc. | Infusion devices and method |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7156872B2 (en) * | 2000-10-26 | 2007-01-02 | Ernst Peter Strecker | Implantable valve system |
US20160346457A1 (en) * | 2005-12-28 | 2016-12-01 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
US9669156B2 (en) * | 2005-12-28 | 2017-06-06 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
US20130129911A1 (en) * | 2005-12-28 | 2013-05-23 | Abbott Diabetes Care Inc. | Infusion Sets for the Delivery of a Therapeutic Substance to a Patient |
US8353881B2 (en) * | 2005-12-28 | 2013-01-15 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US9782076B2 (en) | 2006-02-28 | 2017-10-10 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US10448834B2 (en) | 2006-02-28 | 2019-10-22 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US10220145B2 (en) | 2006-06-30 | 2019-03-05 | Abbott Diabetes Care Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8512244B2 (en) | 2006-06-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated analyte sensor and infusion device and methods therefor |
US11918782B2 (en) | 2006-06-30 | 2024-03-05 | Abbott Diabetes Care Inc. | Integrated analyte sensor and infusion device and methods therefor |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8114031B2 (en) | 2006-07-26 | 2012-02-14 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US8900216B2 (en) | 2006-07-26 | 2014-12-02 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US20090209943A1 (en) * | 2006-07-26 | 2009-08-20 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US9697332B2 (en) | 2006-08-07 | 2017-07-04 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US8727982B2 (en) | 2006-08-07 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US11806110B2 (en) | 2006-08-07 | 2023-11-07 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US11445910B2 (en) | 2006-08-07 | 2022-09-20 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US10206629B2 (en) | 2006-08-07 | 2019-02-19 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8641618B2 (en) | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
US8502682B2 (en) | 2007-06-28 | 2013-08-06 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
US8292873B2 (en) | 2007-08-09 | 2012-10-23 | Boston Scientific Scimed, Inc. | Catheter devices for myocardial injections or other uses |
US20090143748A1 (en) * | 2007-08-09 | 2009-06-04 | Boston Scientific Scimed, Inc | Catheter Devices for Myocardial Injections or Other Uses |
US8298187B2 (en) | 2009-07-07 | 2012-10-30 | Cook Medical Technologies Llc | Fluid injection device |
US9616204B2 (en) | 2012-03-02 | 2017-04-11 | Cook Medical Technologies LLC. | Dilation cap for endoluminal device |
US11967408B2 (en) | 2019-02-12 | 2024-04-23 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
EP4061460A4 (en) * | 2019-11-20 | 2023-08-23 | Clph, Llc | Isolation and attachment catheters and methods for using them |
Also Published As
Publication number | Publication date |
---|---|
US6616626B2 (en) | 2003-09-09 |
EP1351646A2 (en) | 2003-10-15 |
WO2002049695A9 (en) | 2007-08-09 |
AU2002227414A1 (en) | 2002-07-01 |
CA2431421A1 (en) | 2002-06-27 |
US20040019311A1 (en) | 2004-01-29 |
WO2002049695A3 (en) | 2003-03-13 |
DE60139573D1 (en) | 2009-09-24 |
WO2002049695A2 (en) | 2002-06-27 |
AU2002227414A8 (en) | 2007-09-06 |
CA2431421C (en) | 2009-10-27 |
US20020082546A1 (en) | 2002-06-27 |
EP1351646B1 (en) | 2009-08-12 |
US6939322B2 (en) | 2005-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6616626B2 (en) | Infusion devices and method | |
US8475468B2 (en) | Method and apparatus for providing intra-pericardial access | |
US6544230B1 (en) | Catheters, systems and methods for percutaneous in situ arterio-venous bypass | |
US8608727B2 (en) | Delivery system and method | |
US20030093104A1 (en) | Methods and apparatus for providing intra-pericardial access | |
US9302072B2 (en) | Neural injection system and related methods | |
US7857788B2 (en) | Neural injection system and related methods | |
US20050021003A1 (en) | Apparatus for directional guidance of a vascular device and method of use | |
US20040044329A1 (en) | Catheter for cardiac injection and method for delivery of therapeutic agents to specified tissues | |
CA2846741C (en) | Neural injection system and related methods | |
US9808569B2 (en) | Neural injection system and related methods | |
KR100498154B1 (en) | An arrangement and a method for interacting with an internal body organ | |
US9480800B2 (en) | Neural injection system and related methods | |
CN218980020U (en) | Puncture needle assembly for intravenous injection under endoscope | |
US20220330975A1 (en) | Access Catheter | |
US20240091504A1 (en) | Kit and method intended for prostate surgery | |
US20170000974A1 (en) | Echogenic Indwelling Catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |